Mean values of S-Fructosamine, S-Glucose and B-HbA1c over time by increase/reduction of S-Glucose at on average 290 days after the index examination.

<p>Fasting subjects with new or diagnosed type 2 diabetes and with three simultaneous measurements of the biomarkers within one year are included.</p

Subject characteristics by glucose and fasting status.

<p>Data are presented as n, mean (SD) or %. *on average 50–60% reduction in n.</p>†<p>Significant difference between groups, except between NewT2D and DiagnosedT2D,</p>‡<p>% only mandatory education.^§Glomerular filtration rate (eGFR) was estimated by the Epidemiology Collaboration (CKD-EPI) formula (26).</p>£<p>Classification of chronic kidney disease was defined as an eGFR less than 60 mL/min per 1.73 m². Abbreviations: BMI = Body Mass Index, S-Alb = Serum Albumin, S-TG = Serum Triglycerides, S-TC = Serum Total Cholesterol, S-LDLC = Serum Low Density Lipoprotein Cholesterol, S-HDLC = Serum Low Density Lipoprotein Cholesterol, ApoB = Apolipoprotein B, ApoA-I = Apolipoprotein A-I, ApoB/ApoA = Ratio of Apolipoprotein B and Apolipoprotein A-I, S-Crea = Serum Creatinine, CKD = Chronic Kidney Disease, CVD = Cardiovascular Disease, S-Fructosamine = Serum Fructosamine, S-Glucose = Serum Glucose.</p><p>Subject characteristics by glucose and fasting status.</p

Correlations of S-Fructosamine and B-HbA_1c by fasting status, type 2 diabetes (new and diagnosed) and type 1 diabetes.

<p>Fitted regression line with 95% confidence and prediction limits. Reference lines at fructosamine 2.5<b> </b>mmol/L and at HbA_1c 6.5% (48<b> </b>mmol/mol).</p

Overall associations of S-Fructosamine with S-Glucose and B-HbA_1c respectively.

<p>All fasting states and all levels of glycemia included (All subjects).</p

Crude and adjusted odds ratio (OR) with 95% confidence interval (CI) for disability pension (DP) at time of a first coronary artery bypass graft surgery (CABG), among women and men, with regard to sociodemographic and medical factors.

<p>Model I = adjusted for age. Model IV = adjusted for all variables included.</p><p><b>¹</b> Acute Coronary Syndrome: Non-ST-elevated or ST-elevated myocardial infarction.</p><p>Crude and adjusted odds ratio (OR) with 95% confidence interval (CI) for disability pension (DP) at time of a first coronary artery bypass graft surgery (CABG), among women and men, with regard to sociodemographic and medical factors.</p

Crude and adjusted hazard ratio (HR) with 95% confidence interval (CI) for all-cause mortality within five years following a first percutaneous coronary intervention (PCI), among women and men, with disability pension (DP) or no DP (reference group), at time of revascularisation, for all and within each subpopulation.

<p>Model I = Adjusted for Age; model II = Adjusted for: age, level of education, country of birth, type of living area, year of intervention, indication for intervention, diabetes mellitus, in-patient care within 5 years up to one day before intervention, and re-intervention.</p><p>^1. In model II adjusted for all except age.</p><p>Crude and adjusted hazard ratio (HR) with 95% confidence interval (CI) for all-cause mortality within five years following a first percutaneous coronary intervention (PCI), among women and men, with disability pension (DP) or no DP (reference group), at time of revascularisation, for all and within each subpopulation.</p

Patient characteristics, and the five-year (or up through 2006) all-cause mortality, number (n) and percentages (%), aged 30–64 years, on disability pension (DP) or not on DP at the time of first percutaneous coronary intervention (PCI) during the year 1994–2006 and alive 30 days after the intervention.

<p>¹ Percentage of all in each sub-group.</p><p>² Non-ST-elevated or ST-elevated myocardial infarction.</p><p>Patient characteristics, and the five-year (or up through 2006) all-cause mortality, number (n) and percentages (%), aged 30–64 years, on disability pension (DP) or not on DP at the time of first percutaneous coronary intervention (PCI) during the year 1994–2006 and alive 30 days after the intervention.</p

Prevalence ratio of a sick-leave spell >90 days following PCI for <i>all patients</i> and for <i>patients with ≤90 sick-leave days</i> immediately before the intervention.

1<p>Adjusted for age, indication, diabetes, history of cardiovascular disease, socio economic position, and >90 sick-leave days <i>in total</i> the year prior to PCI.</p>*<p>p-value <0.05;</p>**<p>p-value <0.01;</p>***<p>p-value <0.001.</p

First time CABG and PCI in Sweden in 1994–2006.

<p>First time CABG and PCI in Sweden in 1994–2006.</p

Patient characteristics, and the five-year (or up through 2006) all-cause mortality, number (n) and percentages (%), of all patients in Sweden aged 30–64 years, on disability pension (DP) and not on DP at the time of first coronary artery bypass graft surgery (CABG) during the year 1994–2006, and alive 30 days after the intervention.

<p>¹ Percentage of all in each sub-group.</p><p>² Non-ST-elevated or ST-elevated myocardial infarction.</p><p>Patient characteristics, and the five-year (or up through 2006) all-cause mortality, number (n) and percentages (%), of all patients in Sweden aged 30–64 years, on disability pension (DP) and not on DP at the time of first coronary artery bypass graft surgery (CABG) during the year 1994–2006, and alive 30 days after the intervention.</p